Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.
Naunyn Schmiedebergs Arch Pharmacol September 20, 2016 Jakob A. Shimshoni, Ilan Winkler, Ezekiel Golan et al. 23 citations
3,4-Methylenedioxy-N-methylamphetamine (MDMA) has been shown to be effective in the treatment of post-traumatic stress disorder (PTSD) in numerous clinical trials. In the present study, we have characterized the neurochemical binding profiles of three MDMA-benzofuran analogues (1-(benzofuran-5-yl)-propan-2-amine, 5-APB; 1-(benzofuran-6-yl)-N-methylpropan-2-amine, 6-MAPB;...